PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.04%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
11.95%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
-10.64%
Gross profit decline while CRK shows 5.80% growth. Joel Greenblatt would examine competitive position.
-10.61%
Margin decline while CRK shows 7.74% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.91%
Other expenses growth above 1.5x CRK's 4.45%. Michael Burry would check for concerning trends.
8.75%
Operating expenses growth above 1.5x CRK's 4.67%. Michael Burry would check for inefficiency.
11.04%
Total costs growth while CRK reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
10.84%
D&A growth above 1.5x CRK's 4.45%. Michael Burry would check for excessive investment.
-11.07%
EBITDA decline while CRK shows 7.05% growth. Joel Greenblatt would examine position.
-9.45%
EBITDA margin decline while CRK shows 9.21% growth. Joel Greenblatt would examine position.
-21.50%
Operating income decline while CRK shows 5.69% growth. Joel Greenblatt would examine position.
-21.47%
Operating margin decline while CRK shows 7.62% growth. Joel Greenblatt would examine position.
-44.50%
Other expenses reduction while CRK shows 345.10% growth. Joel Greenblatt would examine advantage.
-25.22%
Pre-tax income decline while CRK shows 4.70% growth. Joel Greenblatt would examine position.
-25.19%
Pre-tax margin decline while CRK shows 6.61% growth. Joel Greenblatt would examine position.
14.59%
Tax expense growth 1.25-1.5x CRK's 10.27%. Martin Whitman would scrutinize strategy.
-35.24%
Both companies show declining income. Martin Whitman would check industry conditions.
-35.21%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-34.91%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-34.22%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-7.58%
Share count reduction while CRK shows 0.01% change. Joel Greenblatt would examine strategy.
-7.72%
Diluted share reduction while CRK shows 0.16% change. Joel Greenblatt would examine strategy.